Industry Research Reports

Home > Reports > Medical Care > Stroke Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Stroke Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-11

Pages: 138 Pages

Report ld: 2638923

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Stroke Therapeutics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Stroke Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Stroke Therapeutics by region & country, by Type, and by Application.

The Stroke Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stroke Therapeutics.

Market Segmentation

Report Metric
Details
Report Title
Stroke Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Stroke Therapeutics Companies Covered
Abbott Laboratories, Cordis, Boston Scientific, Siemens, Genentech, Koninklijke Philips, Medtronic, GE Healthcare, Stryker, Merck, Zocere, Inc., Acticor Biotech, DiaMedica Therapeutics, Lumosa Therapeutics, AXONIS Therapeutics , Inc., NovaGo Therapeutics
Global Stroke Therapeutics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Stroke Therapeutics Market, Segment by Type
Intravenous Injection

Oral

Others
Global Stroke Therapeutics Market, Segment by Application
Ischemic Stroke

Hemorrhagic Stroke

Transient Ischemic Attack
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Stroke Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Stroke Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Stroke Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Stroke Therapeutics Product Introduction
    1.2 Global Stroke Therapeutics Market Size Forecast
    1.3 Stroke Therapeutics Market Trends & Drivers
        1.3.1 Stroke Therapeutics Industry Trends
        1.3.2 Stroke Therapeutics Market Drivers & Opportunity
        1.3.3 Stroke Therapeutics Market Challenges
        1.3.4 Stroke Therapeutics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Stroke Therapeutics Players Revenue Ranking (2023)
    2.2 Global Stroke Therapeutics Revenue by Company (2019-2024)
    2.3 Key Companies Stroke Therapeutics Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Stroke Therapeutics Product Offered
    2.5 Key Companies Time to Begin Mass Production of Stroke Therapeutics
    2.6 Stroke Therapeutics Market Competitive Analysis
        2.6.1 Stroke Therapeutics Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Stroke Therapeutics Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Intravenous Injection
        3.1.2 Oral
        3.1.3 Others
    3.2 Global Stroke Therapeutics Sales Value by Type
        3.2.1 Global Stroke Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Stroke Therapeutics Sales Value, by Type (2019-2030)
        3.2.3 Global Stroke Therapeutics Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Ischemic Stroke
        4.1.2 Hemorrhagic Stroke
        4.1.3 Transient Ischemic Attack
    4.2 Global Stroke Therapeutics Sales Value by Application
        4.2.1 Global Stroke Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Stroke Therapeutics Sales Value, by Application (2019-2030)
        4.2.3 Global Stroke Therapeutics Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Stroke Therapeutics Sales Value by Region
        5.1.1 Global Stroke Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Stroke Therapeutics Sales Value by Region (2019-2024)
        5.1.3 Global Stroke Therapeutics Sales Value by Region (2025-2030)
        5.1.4 Global Stroke Therapeutics Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Stroke Therapeutics Sales Value, 2019-2030
        5.2.2 North America Stroke Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Stroke Therapeutics Sales Value, 2019-2030
        5.3.2 Europe Stroke Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Stroke Therapeutics Sales Value, 2019-2030
        5.4.2 Asia Pacific Stroke Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Stroke Therapeutics Sales Value, 2019-2030
        5.5.2 South America Stroke Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Stroke Therapeutics Sales Value, 2019-2030
        5.6.2 Middle East & Africa Stroke Therapeutics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Stroke Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Stroke Therapeutics Sales Value
    6.3 United States
        6.3.1 United States Stroke Therapeutics Sales Value, 2019-2030
        6.3.2 United States Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Stroke Therapeutics Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Stroke Therapeutics Sales Value, 2019-2030
        6.4.2 Europe Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Stroke Therapeutics Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Stroke Therapeutics Sales Value, 2019-2030
        6.5.2 China Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Stroke Therapeutics Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Stroke Therapeutics Sales Value, 2019-2030
        6.6.2 Japan Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Stroke Therapeutics Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Stroke Therapeutics Sales Value, 2019-2030
        6.7.2 South Korea Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Stroke Therapeutics Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Stroke Therapeutics Sales Value, 2019-2030
        6.8.2 Southeast Asia Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Stroke Therapeutics Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Stroke Therapeutics Sales Value, 2019-2030
        6.9.2 India Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Stroke Therapeutics Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Abbott Laboratories
        7.1.1 Abbott Laboratories Profile
        7.1.2 Abbott Laboratories Main Business
        7.1.3 Abbott Laboratories Stroke Therapeutics Products, Services and Solutions
        7.1.4 Abbott Laboratories Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.1.5 Abbott Laboratories Recent Developments
    7.2 Cordis
        7.2.1 Cordis Profile
        7.2.2 Cordis Main Business
        7.2.3 Cordis Stroke Therapeutics Products, Services and Solutions
        7.2.4 Cordis Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.2.5 Cordis Recent Developments
    7.3 Boston Scientific
        7.3.1 Boston Scientific Profile
        7.3.2 Boston Scientific Main Business
        7.3.3 Boston Scientific Stroke Therapeutics Products, Services and Solutions
        7.3.4 Boston Scientific Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.3.5 Siemens Recent Developments
    7.4 Siemens
        7.4.1 Siemens Profile
        7.4.2 Siemens Main Business
        7.4.3 Siemens Stroke Therapeutics Products, Services and Solutions
        7.4.4 Siemens Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.4.5 Siemens Recent Developments
    7.5 Genentech
        7.5.1 Genentech Profile
        7.5.2 Genentech Main Business
        7.5.3 Genentech Stroke Therapeutics Products, Services and Solutions
        7.5.4 Genentech Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.5.5 Genentech Recent Developments
    7.6 Koninklijke Philips
        7.6.1 Koninklijke Philips Profile
        7.6.2 Koninklijke Philips Main Business
        7.6.3 Koninklijke Philips Stroke Therapeutics Products, Services and Solutions
        7.6.4 Koninklijke Philips Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.6.5 Koninklijke Philips Recent Developments
    7.7 Medtronic
        7.7.1 Medtronic Profile
        7.7.2 Medtronic Main Business
        7.7.3 Medtronic Stroke Therapeutics Products, Services and Solutions
        7.7.4 Medtronic Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.7.5 Medtronic Recent Developments
    7.8 GE Healthcare
        7.8.1 GE Healthcare Profile
        7.8.2 GE Healthcare Main Business
        7.8.3 GE Healthcare Stroke Therapeutics Products, Services and Solutions
        7.8.4 GE Healthcare Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.8.5 GE Healthcare Recent Developments
    7.9 Stryker
        7.9.1 Stryker Profile
        7.9.2 Stryker Main Business
        7.9.3 Stryker Stroke Therapeutics Products, Services and Solutions
        7.9.4 Stryker Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.9.5 Stryker Recent Developments
    7.10 Merck
        7.10.1 Merck Profile
        7.10.2 Merck Main Business
        7.10.3 Merck Stroke Therapeutics Products, Services and Solutions
        7.10.4 Merck Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.10.5 Merck Recent Developments
    7.11 Zocere, Inc.
        7.11.1 Zocere, Inc. Profile
        7.11.2 Zocere, Inc. Main Business
        7.11.3 Zocere, Inc. Stroke Therapeutics Products, Services and Solutions
        7.11.4 Zocere, Inc. Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.11.5 Zocere, Inc. Recent Developments
    7.12 Acticor Biotech
        7.12.1 Acticor Biotech Profile
        7.12.2 Acticor Biotech Main Business
        7.12.3 Acticor Biotech Stroke Therapeutics Products, Services and Solutions
        7.12.4 Acticor Biotech Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.12.5 Acticor Biotech Recent Developments
    7.13 DiaMedica Therapeutics
        7.13.1 DiaMedica Therapeutics Profile
        7.13.2 DiaMedica Therapeutics Main Business
        7.13.3 DiaMedica Therapeutics Stroke Therapeutics Products, Services and Solutions
        7.13.4 DiaMedica Therapeutics Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.13.5 DiaMedica Therapeutics Recent Developments
    7.14 Lumosa Therapeutics
        7.14.1 Lumosa Therapeutics Profile
        7.14.2 Lumosa Therapeutics Main Business
        7.14.3 Lumosa Therapeutics Stroke Therapeutics Products, Services and Solutions
        7.14.4 Lumosa Therapeutics Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.14.5 Lumosa Therapeutics Recent Developments
    7.15 AXONIS Therapeutics , Inc.
        7.15.1 AXONIS Therapeutics , Inc. Profile
        7.15.2 AXONIS Therapeutics , Inc. Main Business
        7.15.3 AXONIS Therapeutics , Inc. Stroke Therapeutics Products, Services and Solutions
        7.15.4 AXONIS Therapeutics , Inc. Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.15.5 AXONIS Therapeutics , Inc. Recent Developments
    7.16 NovaGo Therapeutics
        7.16.1 NovaGo Therapeutics Profile
        7.16.2 NovaGo Therapeutics Main Business
        7.16.3 NovaGo Therapeutics Stroke Therapeutics Products, Services and Solutions
        7.16.4 NovaGo Therapeutics Stroke Therapeutics Revenue (US$ Million) & (2019-2024)
        7.16.5 NovaGo Therapeutics Recent Developments

 8 Industry Chain Analysis
    8.1 Stroke Therapeutics Industrial Chain
    8.2 Stroke Therapeutics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Stroke Therapeutics Sales Model
        8.5.2 Sales Channel
        8.5.3 Stroke Therapeutics Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Stroke Therapeutics Market Trends
    Table 2. Stroke Therapeutics Market Drivers & Opportunity
    Table 3. Stroke Therapeutics Market Challenges
    Table 4. Stroke Therapeutics Market Restraints
    Table 5. Global Stroke Therapeutics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Stroke Therapeutics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Stroke Therapeutics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Stroke Therapeutics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Stroke Therapeutics
    Table 10. Global Stroke Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Stroke Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Stroke Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Stroke Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Stroke Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Stroke Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Stroke Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Stroke Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Stroke Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Stroke Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Stroke Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Stroke Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Stroke Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Stroke Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Stroke Therapeutics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Stroke Therapeutics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Stroke Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Stroke Therapeutics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Stroke Therapeutics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Laboratories Basic Information List
    Table 32. Abbott Laboratories Description and Business Overview
    Table 33. Abbott Laboratories Stroke Therapeutics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Stroke Therapeutics Business of Abbott Laboratories (2019-2024)
    Table 35. Abbott Laboratories Recent Developments
    Table 36. Cordis Basic Information List
    Table 37. Cordis Description and Business Overview
    Table 38. Cordis Stroke Therapeutics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Stroke Therapeutics Business of Cordis (2019-2024)
    Table 40. Cordis Recent Developments
    Table 41. Boston Scientific Basic Information List
    Table 42. Boston Scientific Description and Business Overview
    Table 43. Boston Scientific Stroke Therapeutics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Stroke Therapeutics Business of Boston Scientific (2019-2024)
    Table 45. Boston Scientific Recent Developments
    Table 46. Siemens Basic Information List
    Table 47. Siemens Description and Business Overview
    Table 48. Siemens Stroke Therapeutics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Stroke Therapeutics Business of Siemens (2019-2024)
    Table 50. Siemens Recent Developments
    Table 51. Genentech Basic Information List
    Table 52. Genentech Description and Business Overview
    Table 53. Genentech Stroke Therapeutics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Stroke Therapeutics Business of Genentech (2019-2024)
    Table 55. Genentech Recent Developments
    Table 56. Koninklijke Philips Basic Information List
    Table 57. Koninklijke Philips Description and Business Overview
    Table 58. Koninklijke Philips Stroke Therapeutics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Stroke Therapeutics Business of Koninklijke Philips (2019-2024)
    Table 60. Koninklijke Philips Recent Developments
    Table 61. Medtronic Basic Information List
    Table 62. Medtronic Description and Business Overview
    Table 63. Medtronic Stroke Therapeutics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Stroke Therapeutics Business of Medtronic (2019-2024)
    Table 65. Medtronic Recent Developments
    Table 66. GE Healthcare Basic Information List
    Table 67. GE Healthcare Description and Business Overview
    Table 68. GE Healthcare Stroke Therapeutics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Stroke Therapeutics Business of GE Healthcare (2019-2024)
    Table 70. GE Healthcare Recent Developments
    Table 71. Stryker Basic Information List
    Table 72. Stryker Description and Business Overview
    Table 73. Stryker Stroke Therapeutics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Stroke Therapeutics Business of Stryker (2019-2024)
    Table 75. Stryker Recent Developments
    Table 76. Merck Basic Information List
    Table 77. Merck Description and Business Overview
    Table 78. Merck Stroke Therapeutics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Stroke Therapeutics Business of Merck (2019-2024)
    Table 80. Merck Recent Developments
    Table 81. Zocere, Inc. Basic Information List
    Table 82. Zocere, Inc. Description and Business Overview
    Table 83. Zocere, Inc. Stroke Therapeutics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Stroke Therapeutics Business of Zocere, Inc. (2019-2024)
    Table 85. Zocere, Inc. Recent Developments
    Table 86. Acticor Biotech Basic Information List
    Table 87. Acticor Biotech Description and Business Overview
    Table 88. Acticor Biotech Stroke Therapeutics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Stroke Therapeutics Business of Acticor Biotech (2019-2024)
    Table 90. Acticor Biotech Recent Developments
    Table 91. DiaMedica Therapeutics Basic Information List
    Table 92. DiaMedica Therapeutics Description and Business Overview
    Table 93. DiaMedica Therapeutics Stroke Therapeutics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Stroke Therapeutics Business of DiaMedica Therapeutics (2019-2024)
    Table 95. DiaMedica Therapeutics Recent Developments
    Table 96. Lumosa Therapeutics Basic Information List
    Table 97. Lumosa Therapeutics Description and Business Overview
    Table 98. Lumosa Therapeutics Stroke Therapeutics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Stroke Therapeutics Business of Lumosa Therapeutics (2019-2024)
    Table 100. Lumosa Therapeutics Recent Developments
    Table 101. AXONIS Therapeutics , Inc. Basic Information List
    Table 102. AXONIS Therapeutics , Inc. Description and Business Overview
    Table 103. AXONIS Therapeutics , Inc. Stroke Therapeutics Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Stroke Therapeutics Business of AXONIS Therapeutics , Inc. (2019-2024)
    Table 105. AXONIS Therapeutics , Inc. Recent Developments
    Table 106. NovaGo Therapeutics Basic Information List
    Table 107. NovaGo Therapeutics Description and Business Overview
    Table 108. NovaGo Therapeutics Stroke Therapeutics Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Stroke Therapeutics Business of NovaGo Therapeutics (2019-2024)
    Table 110. NovaGo Therapeutics Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. Stroke Therapeutics Downstream Customers
    Table 114. Stroke Therapeutics Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Stroke Therapeutics Product Picture
    Figure 2. Global Stroke Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Stroke Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Stroke Therapeutics Report Years Considered
    Figure 5. Global Stroke Therapeutics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Stroke Therapeutics Revenue in 2023
    Figure 7. Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Intravenous Injection Picture
    Figure 9. Oral Picture
    Figure 10. Others Picture
    Figure 11. Global Stroke Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Stroke Therapeutics Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Ischemic Stroke
    Figure 14. Product Picture of Hemorrhagic Stroke
    Figure 15. Product Picture of Transient Ischemic Attack
    Figure 16. Global Stroke Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Stroke Therapeutics Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Stroke Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Stroke Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Stroke Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Stroke Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Stroke Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Stroke Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Stroke Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Stroke Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Stroke Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Stroke Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Stroke Therapeutics Sales Value (%), (2019-2030)
    Figure 29. United States Stroke Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Stroke Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Stroke Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Stroke Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Stroke Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Stroke Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Stroke Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Stroke Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Stroke Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Stroke Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Stroke Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Stroke Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Stroke Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Stroke Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Stroke Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 50. Stroke Therapeutics Industrial Chain
    Figure 51. Stroke Therapeutics Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

The global market for Stroke Therapeutics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Stroke Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Stroke Therapeutics by region & country, by Type, and by Application.

The Stroke Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stroke Therapeutics.

Market Segmentation